Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion type Assertion NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_head.
- NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion description "[In an effort to develop a genetic therapy for the treatment of breast cancer, we constructed adenoviral vectors containing either the beta-galactosidase (beta-gal) reporter gene or the herpes simplex thymidine kinase (HSVtk) suicide gene driven by breast tissue-specific promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_provenance.
- NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion evidence source_evidence_literature NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_provenance.
- NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion SIO_000772 10505111 NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_provenance.
- NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion wasDerivedFrom befree-20140225 NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_provenance.
- NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_assertion wasGeneratedBy ECO_0000203 NP495994.RAt7iu_JKLp4fTyGCDx6PLsMCvx9KaBujn552R93W4H6g130_provenance.